Medical specialists from Japan tagged as investigators in clinical trials studying Hepatitis B, Chronic
Total 17 results
-
Atsumasa KomoriSeen in:
- Nagasaki, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT05630820 (Principal Investigator)
- NCT05583344 (Principal Investigator)
- NCT04954859 (Principal Investigator)
-
Kazuo NotsumataSeen in:
- Fukui, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT05630820 (Principal Investigator)
- NCT05583344 (Principal Investigator)
-
Ken FuruyaSeen in:
- Hokkaido, GSK Investigational Site
- Hokkaido, Sapporo-shi, JCHO Hokkaido Hospital
Trials:- NCT04166773 (Principal Investigator)
- NCT05630820 (Principal Investigator)
-
Masanori AtsukawaSeen in:
- Tokyo, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT05630820 (Principal Investigator)
- NCT04954859 (Principal Investigator)
Conditions: -
Nami MoriSeen in:
- Hiroshima, GSK Investigational Site
Trials:- NCT05630820 (Principal Investigator)
- NCT04954859 (Principal Investigator)
Conditions: -
Naoya SakamotoSeen in:
- Hokkaido, GSK Investigational Site
Trials:- NCT05630820 (Principal Investigator)
Conditions: -
Satoyoshi YamashitaSeen in:
- Yamaguchi, GSK Investigational Site
Trials:- NCT05630820 (Principal Investigator)
Conditions: -
Shigetoshi FujiyamaSeen in:
- Kumamoto, GSK Investigational Site
- Kumamoto, Kumamoto Shinto General Hospital
Trials:- NCT05630807 (Principal Investigator)
- NCT04166773 (Principal Investigator)
- NCT04954859 (Principal Investigator)
Conditions: -
Shinya MinamiSeen in:
- Hokkaido, GSK Investigational Site
Trials:- NCT05630807 (Principal Investigator)
Conditions: -
Tadashi NamisakiSeen in:
- Nara, GSK Investigational Site
Trials:- NCT04950127 (Principal Investigator)
- NCT04167358 (Principal Investigator)
- NCT05630820 (Principal Investigator)
Conditions: -
Takeshi MatsuiSeen in:
- Hokkaido, GSK Investigational Site
Trials:- NCT05630820 (Principal Investigator)
Conditions: -
Takuya KomuraSeen in:
- Ishikawa, GSK Investigational Site
Trials:- NCT05630820 (Principal Investigator)
- NCT04954859 (Principal Investigator)
Conditions: -
Takuya NaganoSeen in:
- Kagawa, GSK Investigational Site
Trials:- NCT05630820 (Principal Investigator)
- NCT05583344 (Principal Investigator)
-
Tetsuo TakeharaSeen in:
- Osaka, GSK Investigational Site
Trials:- NCT05630820 (Principal Investigator)
- NCT04954859 (Principal Investigator)
Conditions: -
Toru IshikawaSeen in:
- Niigata, GSK Investigational Site
Trials:- NCT05630820 (Principal Investigator)
Conditions: -
Yasuhito TanakaSeen in:
- Kumamoto, GSK Investigational Site
Trials:- NCT05630820 (Principal Investigator)
- NCT04954859 (Principal Investigator)
Conditions: -
Yuichiro SuzukiSeen in:
- Yamanashi, GSK Investigational Site
Trials:- NCT05630820 (Principal Investigator)
- NCT05583344 (Principal Investigator)
Clinical Trials on Hepatitis B, Chronic
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Gilead SciencesNot yet recruiting
-
Tongji HospitalGilead SciencesRecruiting
-
Jiangsu HengRui Medicine Co., Ltd.Unknown
-
Changhai HospitalCompleted
-
Tongji HospitalChia Tai Tianqing Pharmaceutical Group Co., Ltd.UnknownChronic Hepatitis b
-
Zhongshan Hospital Xiamen UniversityUnknownHealthy | Chronic Hepatitis B InfectionChina
-
Brii Biosciences LimitedVir Biotechnology, Inc.Active, not recruitingChronic Hepatitis B Virus InfectionSingapore, Thailand, Australia, China, Korea, Republic of
-
Nanfang Hospital of Southern Medical UniversityRecruiting
-
IlDong Pharmaceutical Co LtdRecruitingChronic Hepatitis bKorea, Republic of